From Concept to Practice: How to Tactically Design a Feasible Outcomes-Based Contract in Oncology?

Speaker(s)

Discussion Leader: Mark Trusheim, MS, BS, MIT Center for Biomedical Innovation, Massachusetts Institute of Technology, Cambridge, MA, USA
Discussants: Jamie Foley, MA, Economics, Global Oncology Value-Based Innovation, Takeda, Cambridge, MA, USA; Ann Nguyen, PharmD, UnitedHealthcare, West Hills, CA, USA; Ron Potts, MD, 6 Degrees Health, Portland, OR, USA

PURPOSE:

The purpose of this workshop is to drill down on specific components intrinsic to the tactical design of a successful outcomes-based contract in oncology, address payer uncertainties, and accelerate patient access to innovative medicines.

DESCRIPTION:

The concepts of value-based contracting (VBC) have been made clear in the literature, however there is a gap between these concepts and executional realities.

The discussion leader (Mark Trusheim) will start by introducing the concept of VBCs, narrowing quickly to focus on outcomes-based contracts (OBCs) in oncology, including definitions, pros and cons, and examples of how they have been used. (7 mins)

The industry lead (Jamie Foley) will provide their perspective, including rationale and practical guidance for building OBCs, including internal and external barriers and best practices. (7 mins)

Finally, the payer leads (Ann Nguyen and Ron Potts) will provide their perspective, including preferred engagement, considerations for trust and transparency, and common challenges that limit acceptance and execution. (7 mins)

Next the discussion leader will provide a mock launch scenario of an oncology medicine with details to support the exploration of key tactical considerations for building an OBC. (30 mins)

In real-time, the audience will be engaged through various polling questions on three key topics:

1. Contract metric selection and eligible population

2. Data collection challenges

3. Contract reconciliation and adjudication, e.g., aligning contractual expectations with the reality of imperfect data collection, etc.

After each question, the presenters will provide their respective perspective and comments on the audience’s responses.

The workshop will conclude with practical considerations from each presenter, including how industry and payers can work better together to design feasible OBCs. (9 mins)

Stakeholders that would benefit from this session: Payers, industry, researchers and consultants who are interested in learning more about the feasibility aspects and execution/implementation challenges of VBCs, payment innovation and outcomes tracking.

Code

302

Topic

Health Policy & Regulatory